London: Interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India and known as Covaxin, reports that two doses offer 77.8% protection against symptomatic COVID-19 ...
Delhi (JEN): Indian Prime Minister Narendra Modi on Wednesday said coronavirus vaccines should now be taken to the doorsteps of the people, and there should be an equal focus on the secon ...
Brasilia: Thousands of Brazilians hit the roads on Saturday, protesting against President Jair Bolsonaro's response to allegations of potential corruption within his health ministry i ...
Washington: A study conducted by the US' National Institute of Health has said India's COVAXIN, which was developed by Bharat Biotech in collaboration with the Indian Counci ...
New Delhi: Indian Prime Minister Narendra Modi on Saturday launched the world's biggest Covid-19 vaccination drive in the nation, which is one of the worst Novel Coronavirus-hit count ...
Beijing: China has officially joined the World Health Organization-led COVID-19 Vaccine Global Access (COVAX) Facility, Foreign Ministry spokeswoman Hua Chunying said on Friday.
New York: There is likely only a slim possibility of people being reinfected with COVID-19, the UN health agency said on Tuesday, following reports in Hong Kong that a man had contracted ...
